Clinical trials recruiting for Non-small Cell Lung Cancer Stage IV
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Ohio | 2 |
| Arizona | 1 |
| California | 1 |
| Florida | 1 |
| Michigan | 1 |
| Missouri | 1 |
| New Jersey | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
- First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
- Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
- Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer
- [177Lu]Lu-AKIR001 First-in-human Study
Related conditions
Trials recruiting for Non-small Cell Lung Cancer Stage IV often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Non-small Cell Lung Cancer Stage IV trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.